{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "ACE2 receptors",
      "Acute respiratory distress syndrome (ARDS)",
      "COVID-19",
      "Coronaviruses",
      "SARS-CoV-2",
      "Spike glycoprotein"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33261606",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "12"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "12",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "318",
      "10.1186/s12931-020-01581-z"
    ],
    "Journal": {
      "ISSN": "1465-993X",
      "JournalIssue": {
        "Volume": "21",
        "Issue": "1",
        "PubDate": {
          "Year": "2020",
          "Month": "Dec",
          "Day": "01"
        }
      },
      "Title": "Respiratory research",
      "ISOAbbreviation": "Respir Res"
    },
    "ArticleTitle": "SARS coronavirus 2: from genome to infectome.",
    "Pagination": {
      "StartPage": "318",
      "MedlinePgn": "318"
    },
    "Abstract": {
      "AbstractText": [
        "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) belongs to the group of Betacoronaviruses. The SARS-CoV-2 is closely related to SARS-CoV-1\u00a0and probably originated either from bats or pangolins. SARS-CoV-2 is an etiological agent of COVID-19, causing mild to severe respiratory disease which escalates to acute respiratory distress syndrome (ARDS) or multi-organ failure. The virus was first reported from the animal market in Hunan, Hubei province of China in the month of December, 2019, and was\u00a0rapidly transmitted from animal to human and human-to-human. The human-to-human transmission can occur directly or via droplets generated during coughing and sneezing. Globally, around 53.9 million cases of COVID-19 have been registered with 1.31 million confirmed deaths. The people\u2009>\u200960\u00a0years,\u00a0persons suffering from comorbid conditions and\u00a0immunocompromised individuals are more susceptible to COVID-19 infection. The virus primarily targets the upper and the lower respiratory tract and quickly disseminates to other organs. SARS-CoV-2 dysregulates immune signaling pathways which generate cytokine storm and leads to the acute respiratory distress syndrome\u00a0and other multisystemic disorders."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-0240-2068"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Biology Unit, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India."
          }
        ],
        "LastName": "Rastogi",
        "ForeName": "Meghana",
        "Initials": "M"
      },
      {
        "Identifier": [
          "0000-0003-0900-019X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Biology Unit, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India."
          }
        ],
        "LastName": "Pandey",
        "ForeName": "Neha",
        "Initials": "N"
      },
      {
        "Identifier": [
          "0000-0002-0833-8693"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Biology Unit, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India."
          }
        ],
        "LastName": "Shukla",
        "ForeName": "Astha",
        "Initials": "A"
      },
      {
        "Identifier": [
          "0000-0002-8802-1169"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Biology Unit, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India. sunitsingh2000@bhu.ac.in."
          }
        ],
        "LastName": "Singh",
        "ForeName": "Sunit K",
        "Initials": "SK"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Respir Res",
    "NlmUniqueID": "101090633",
    "ISSNLinking": "1465-9921"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "immunology",
        "therapy",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genome, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics",
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Zoonoses"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The authors declare that they have no competing interests."
}